The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
Det Glutenfrie Verksted is funding research on coeliac disease
July 2, 2018 2:40 PM
Since January 2018, Det Glutenfrie Verksted by Monica Hellmann, Nordic Refreshment Company AS, has donated 1 NOK per bag of gluten free baking mix to research on coeliac disease. The donation is supporting research under the management by Prof Ludvig M. Sollid and Knut E.A. Lundin who are very grateful for this generous gift.
Group leader Cisca Wijmenga awarded the UEG Research Prize 2018
July 2, 2018 9:50 AM
Professor Cisca Wijmenga is awarded the distinguished UEG Research Prize 2018 for her outstanding work “A celiac mucosal barrier-on-chip model to investigate its role in initiation of celiac disease”.
- A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease May 23, 2018 11:00 AM
- Coloc-stats: a unified web interface to perform colocalization analysis of genomic features June 7, 2018 11:00 AM
- Reply June 13, 2018 11:00 AM